- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Keeps BioPharma Inc (256940)
The Keeps BioPharma share price today is 8,520 %REPORT_CURRENCY%, view KQ 256940 stock exchange data. Track the latest Keeps BioPharma share price with real-time updates on 256940 stock performance including market cap, day range, 52-week range and dividend yield. Access 256940 charts, earnings dates and analyst estimates to support your investment decisions.
KOSDAQ
Currency in KRW
8,520
-200(-2.29%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,520
8,960
52 wk Range
6,600
22,150
256940 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,5208,960
52 wk Range
6,60022,150
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
256940 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
13,000
Upside
+52.58%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products. The company is also involved in bio research and development business; waste battery recycling; and other non-ferrous metal smelting, refining, and alloy manufacturing. The company was formerly known as KPS Corporation and changed its name to Keeps Biopharma Inc. in April 2025. Keeps Biopharma Inc. was founded in 2000 and is headquartered in Hwaseong-si, South Korea.
Compare 256940 to Peers and Sector
Metrics to compare | 256940 | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship Relationship256940PeersSector | |
|---|---|---|---|---|
P/E Ratio | −17.5x | −4.8x | 12.9x | |
PEG Ratio | 0.02 | 0.05 | 0.01 | |
Price/Book | 2.8x | 1.2x | 2.4x | |
Price / LTM Sales | 1.0x | 1.6x | 2.4x | |
Upside (Analyst Target) | - | −7.0% | 23.9% | |
Fair Value Upside | Unlock | 0.8% | 3.7% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 13,000
(+52.58% Upside)
Earnings
Latest Release
23-03-2026
EPS / Forecast
-438.54 / --
Revenue / Forecast
45.23B / 60.3B
FAQ
What Is the Keeps BioPharma (256940) Share Price Today?
The Keeps BioPharma share price today is 8,520 KRW.
What is the current Keeps BioPharma (256940) share price and day range?
As of 26-04-2026, the Keeps BioPharma share price is 8,520 KRW, with a previous close of 8,720 KRW. The share price has ranged from 8,520 to 8,960 KRW today, while the 52-week range spans from 6,600 to 22,150 KRW.
What Is the Keeps BioPharma Market Cap?
As of today, Keeps BioPharma market cap is 171.07B.
What Is the Keeps BioPharma (256940) Share Price Target?
The average 12-month share price target for Keeps BioPharma is 13,000 KRW, with a high estimate of 13000 KRW and a low estimate of 13000 KRW. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +52.58% Upside potential.
What Is Keeps BioPharma's Earnings Per Share (TTM)?
The Keeps BioPharma EPS (TTM) is -499.
When Is the Next Keeps BioPharma Earnings Date?
Keeps BioPharma will release its next earnings report on 18-05-2026.
From a Technical Analysis Perspective, Is 256940 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
What Stock Exchange Does Keeps BioPharma Trade On?
Keeps BioPharma is listed and trades on the KOSDAQ.
What Is the Stock Symbol for Keeps BioPharma?
The stock symbol for Keeps BioPharma is "256940."
How Many Times Has Keeps BioPharma Stock Split?
Keeps BioPharma has split 1 times.
How Many Employees Does Keeps BioPharma Have?
Keeps BioPharma has 109 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.